Larotrectinib sulfate is the sulfate salt of larotrectinib, a first-in-class, highly selective, and potent oral inhibitor of the tropomyosin receptor kinase (TRK) family, used to treat solid tumors harboring NTRK gene fusions regardless of tumor location.